Amenorrhea following use of oral contraceptives.
D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology / Q000652:urine; D001831:Body Temperature / Q000187:drug effects; D002582:Cervix Mucus / Q000187:drug effects / Q000503:physiopathology; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004338:Drug Combinations; D004717:Endometrium / Q000187:drug effects / Q000503:physiopathology; D005040:Ethynodiol Diacetate / Q000009:adverse effects; D005260:Female; D005640:Follicle Stimulating Hormone / Q000652:urine; D006801:Humans; D008297:Male; D008656:Mestranol / Q000009:adverse effects; D009640:Norethindrone / Q000009:adverse effects; D009641:Norethynodrel / Q000009:adverse effects; D010060:Ovulation / Q000187:drug effects; D010298:Parity; D013075:Sperm Capacitation / Q000187:drug effects; D013997:Time Factors
D015068:17-Ketosteroids; D003276:Contraceptives, Oral; D004338:Drug Combinations; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D005640:Follicle Stimulating Hormone; D008656:Mestranol; D009640:Norethindrone